Skip to Main Content

Paper Details

The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma.
Leuk Res
21
2017
Author NameAffiliation
Jeffrey J DelrowFred Hutchinson Cancer Research Center
  • 1 - 1

Datasets

Release 1.2